Ex vivo effects of oclacitinib and cyclosporin A on canine immune response to Leishmania infantum. [PDF]
Murillo-Picco A +4 more
europepmc +1 more source
Effects of meglumine antimoniate and allopurinol treatment on the fecal microbiome profile in dogs with leishmaniosis. [PDF]
Martí-Carreras J +8 more
europepmc +1 more source
Unveiling prognostic indicators in canine leishmaniosis: two decades of evidence. [PDF]
Sarquis J +8 more
europepmc +1 more source
Clinical and Clinico-Pathological Observations of the Erythrocyte Sedimentation Rate in Dogs Affected by Leishmaniosis and Monitored During Antileishmanial Treatment. [PDF]
Lubas G +8 more
europepmc +1 more source
Evaluation of the safety and immunogenicity of a peptide vaccine against canine leishmaniosis: a double-blind, multicenter, controlled clinical trial in dogs. [PDF]
Hurtado-Morillas C +6 more
europepmc +1 more source
Emergence of Autochthonous Leishmania (Mundinia) martiniquensis Infections in Horses, Czech Republic and Austria, 2019-2023. [PDF]
Modrý D +9 more
europepmc +1 more source
A novel 3R-compliant ex vivo approach to assess ectoparasiticide repellency against Phlebotomus perniciosus in dogs. [PDF]
Sibari A +6 more
europepmc +1 more source
Abscence of specific humoral response in three dogs with clinical leishmaniosis. [PDF]
Villanueva-Saz S +8 more
europepmc +1 more source
Urinary Gamma-Glutamil Transferase as an Early Biomarker of Renal Disease in Dogs with Leishmaniosis. [PDF]
Ruiz P +5 more
europepmc +1 more source

